• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静电纺丝法制备环孢素微纤维及其理化性质表征

Formulation and Physicochemical Characterization of Cyclosporine Microfiber by Electrospinning.

作者信息

Mirzaeei Shahla, Mohammadi Ghobad, Fattahi Navid, Mohammadi Pardis, Fattahi Ali, Nikbakht Mohammad Reza, Adibkia Khosro

机构信息

Pharmaceutical Sciences Research Center, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.

出版信息

Adv Pharm Bull. 2019 Jun;9(2):249-254. doi: 10.15171/apb.2019.028. Epub 2019 Jun 1.

DOI:10.15171/apb.2019.028
PMID:31380250
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6664123/
Abstract

The objective of this study was to improve the permeability and water solubility rate of a poor water soluble drug, cyclosporine A (CsA). In order to improve the drug dissolution rate and oral bioavailability, electrospinning method was used as an approach to prepare. The fibers were evaluated for surface morphology, thermal characterizations, drug crystallinity, drug release and bioavailability studies. Scanning electron microscope (SEM) results confirmed that the fibers were in microsize range and the size of the fibers was in the rang of 0.2 to 2 micron. Differential scanning calorimetry (DSC) and powder X-ray diffractometry (XRPD) analysis ensured that the crystalline lattice of drug were weakened or destroyed in the fibers. The drug release was 15.28%, 20.67%, and 32.84% from pure drug, fibers of formulation B, and formulation A, respectively. study results indicated that the bioavailability parameters of the optimized fiber formulation were improved and the maximum concentration (C) were significantly higher for fibers (3001 ng/mL) than for pure drug (2550 ng/mL). The dissolution rate of the formulations was dependent on the nature and ratio of drug to carriers. The physicochemical properties showed that the optimized mixture of polyethylene glycol (PEG) and povidone (PVP) fibers could be an effective carrier for CsA delivery. PEG and PVP fibers improved the absolute bioavailability and drug dissolution rate with appropriate physicochemical properties.

摘要

本研究的目的是提高难溶性药物环孢素A(CsA)的渗透性和水溶性速率。为了提高药物的溶出速率和口服生物利用度,采用静电纺丝法进行制备。对纤维进行了表面形态、热特性、药物结晶度、药物释放和生物利用度研究。扫描电子显微镜(SEM)结果证实纤维处于微米尺寸范围,纤维尺寸在0.2至2微米之间。差示扫描量热法(DSC)和粉末X射线衍射法(XRPD)分析确保了药物的晶格在纤维中被削弱或破坏。纯药物、制剂B纤维和制剂A的药物释放率分别为15.28%、20.67%和32.84%。研究结果表明,优化后的纤维制剂的生物利用度参数得到改善,纤维的最大浓度(Cmax)(3001 ng/mL)显著高于纯药物(2550 ng/mL)。制剂的溶出速率取决于药物与载体的性质和比例。物理化学性质表明,聚乙二醇(PEG)和聚维酮(PVP)纤维的优化混合物可能是CsA递送的有效载体。PEG和PVP纤维具有适当的物理化学性质,提高了绝对生物利用度和药物溶出速率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f098/6664123/d10652157597/apb-9-249-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f098/6664123/53832dadb8a3/apb-9-249-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f098/6664123/dfb1574d5de9/apb-9-249-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f098/6664123/18c926d2447b/apb-9-249-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f098/6664123/d10652157597/apb-9-249-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f098/6664123/53832dadb8a3/apb-9-249-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f098/6664123/dfb1574d5de9/apb-9-249-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f098/6664123/18c926d2447b/apb-9-249-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f098/6664123/d10652157597/apb-9-249-g004.jpg

相似文献

1
Formulation and Physicochemical Characterization of Cyclosporine Microfiber by Electrospinning.静电纺丝法制备环孢素微纤维及其理化性质表征
Adv Pharm Bull. 2019 Jun;9(2):249-254. doi: 10.15171/apb.2019.028. Epub 2019 Jun 1.
2
Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation.使用聚合物纳米颗粒系统提高非诺贝特的口服生物利用度:理化特性及体内研究
Int J Nanomedicine. 2015 Mar 5;10:1819-30. doi: 10.2147/IJN.S78895. eCollection 2015.
3
Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.洛伐他汀与聚乙二醇4000和聚乙烯吡咯烷酮K30固体分散体的物理化学表征及溶出度研究
Pharm Dev Technol. 2007;12(1):21-33. doi: 10.1080/10837450601166510.
4
Orthogonal experimental preparation of Sanguis Draconis- Polyvinylpyrrolidone microfibers by electrospinning.静电纺丝法制备正交设计血竭-聚乙烯吡咯烷酮微纤维
J Biomater Sci Polym Ed. 2019 Mar;30(4):308-321. doi: 10.1080/09205063.2019.1570432. Epub 2019 Feb 9.
5
Preparation and in vitro evaluation of hydrophilic fenretinide nanoparticles.亲水性维甲酸纳米颗粒的制备及体外评价
Int J Pharm. 2015 Feb 20;479(2):329-37. doi: 10.1016/j.ijpharm.2014.12.052. Epub 2014 Dec 24.
6
Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.具有改善溶出度和生物利用度的鸢尾黄素固体分散体的制备、表征及体内外评价
Eur J Drug Metab Pharmacokinet. 2016 Aug;41(4):413-22. doi: 10.1007/s13318-015-0265-6. Epub 2015 Feb 11.
7
A novel application of electrospinning technique in sublingual membrane: characterization, permeation and in vivo study.
Drug Dev Ind Pharm. 2016 Aug;42(8):1365-74. doi: 10.3109/03639045.2015.1135939. Epub 2016 Feb 1.
8
Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.新型脂质制剂增强了难溶性模型药物吡罗昔康的体外溶出度和通透性特征。
Int J Pharm. 2005 Sep 14;301(1-2):209-16. doi: 10.1016/j.ijpharm.2005.05.032.
9
Solid state and dissolution rate characterization of co-ground mixtures of nifedipine and hydrophilic carriers.硝苯地平与亲水性载体共研磨混合物的固态及溶解速率表征
Drug Dev Ind Pharm. 2005 Sep;31(8):719-28. doi: 10.1080/03639040500216097.
10
Novel electrosprayed nanospherules for enhanced aqueous solubility and oral bioavailability of poorly water-soluble fenofibrate.用于提高难溶性非诺贝特的水溶性和口服生物利用度的新型电喷雾纳米球。
Int J Nanomedicine. 2016 Jan 12;11:213-21. doi: 10.2147/IJN.S97496. eCollection 2016.

引用本文的文献

1
In Vitro Characterization of a Cyclosporine Eluted Polymeric Stent Manufactured by Liquid Crystal Display 3D Technology.采用液晶显示3D技术制造的环孢素洗脱聚合物支架的体外特性研究
AAPS PharmSciTech. 2025 Mar 6;26(3):80. doi: 10.1208/s12249-025-03066-y.
2
Cyclosporine A loaded brain targeting nanoparticle to treat cerebral ischemia/reperfusion injury in mice.载环孢素 A 的脑靶向纳米粒治疗小鼠脑缺血/再灌注损伤。
J Nanobiotechnology. 2022 Jun 3;20(1):256. doi: 10.1186/s12951-022-01474-x.
3
Design of Novel Nanoemulsion Formulations for Topical Ocular Delivery of Itraconazole: Development, Characterization and Bioassay.

本文引用的文献

1
Alternative matrices for therapeutic drug monitoring of immunosuppressive agents using LC-MS/MS.使用液相色谱-串联质谱法进行免疫抑制剂治疗药物监测的替代基质
Bioanalysis. 2015;7(8):1037-58. doi: 10.4155/bio.15.35.
2
Electrospinning of polymeric nanofibers for drug delivery applications.用于药物输送应用的聚合物纳米纤维的静电纺丝。
J Control Release. 2014 Jul 10;185:12-21. doi: 10.1016/j.jconrel.2014.04.018. Epub 2014 Apr 22.
3
Drug delivery with PEGylated MoS2 nano-sheets for combined photothermal and chemotherapy of cancer.基于聚乙二醇化 MoS2 纳米片的药物传递用于癌症的光热与化疗联合治疗。
用于伊曲康唑眼部局部给药的新型纳米乳剂配方设计:开发、表征及生物测定
Adv Pharm Bull. 2022 Jan;12(1):93-101. doi: 10.34172/apb.2022.009. Epub 2021 Feb 6.
4
Metronidazole- and Amoxicillin-Loaded PLGA and PCL Nanofibers as Potential Drug Delivery Systems for the Treatment of Periodontitis: In Vitro and In Vivo Evaluations.载有甲硝唑和阿莫西林的聚乳酸-羟基乙酸共聚物及聚己内酯纳米纤维作为治疗牙周炎的潜在药物递送系统:体外和体内评估
Biomedicines. 2021 Aug 7;9(8):975. doi: 10.3390/biomedicines9080975.
5
A Review on Ocular Novel Drug Delivery Systems of Antifungal Drugs: Functional Evaluation and Comparison of Conventional and Novel Dosage Forms.抗真菌药物眼部新型给药系统综述:传统剂型与新型剂型的功能评估及比较
Adv Pharm Bull. 2021 Jan;11(1):28-38. doi: 10.34172/apb.2021.003. Epub 2020 Nov 7.
Adv Mater. 2014 Jun 4;26(21):3433-40. doi: 10.1002/adma.201305256. Epub 2014 Feb 20.
4
Approaches for enhancing oral bioavailability of peptides and proteins.提高肽和蛋白质口服生物利用度的方法。
Int J Pharm. 2013 Apr 15;447(1-2):75-93. doi: 10.1016/j.ijpharm.2013.02.030. Epub 2013 Feb 18.
5
pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.pH 敏感型聚合物纳米粒提高肽/蛋白类药物和难溶性药物的口服生物利用度。
Eur J Pharm Biopharm. 2012 Oct;82(2):219-29. doi: 10.1016/j.ejpb.2012.07.014. Epub 2012 Aug 3.
6
Enhanced dissolution of inhalable cyclosporine nano-matrix particles with mannitol as matrix former.甘露醇作为基质前体制备吸入性环孢素纳米矩阵粒子的增溶作用。
Int J Pharm. 2011 Nov 25;420(1):34-42. doi: 10.1016/j.ijpharm.2011.08.010. Epub 2011 Aug 16.
7
Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles.环孢素 A 包封于单油酸甘油酯/泊洛沙姆 407 立方纳米粒中的药代动力学和在比格犬中的口服生物利用度增强。
Int J Nanomedicine. 2010 Feb 2;5:13-23.
8
Improvement of cyclosporine A bioavailability by incorporating ethyl docosahexaenoate in the microemulsion as an oil excipient.通过将二十二碳六烯酸乙酯作为油相辅料纳入微乳剂来提高环孢素A的生物利用度。
Eur J Pharm Biopharm. 2009 Oct;73(2):247-52. doi: 10.1016/j.ejpb.2009.06.011. Epub 2009 Jun 26.
9
Oral fast-dissolving drug delivery membranes prepared from electrospun polyvinylpyrrolidone ultrafine fibers.由静电纺丝聚乙烯吡咯烷酮超细纤维制备的口腔速溶给药膜。
Nanotechnology. 2009 Feb 4;20(5):055104. doi: 10.1088/0957-4484/20/5/055104. Epub 2009 Jan 9.
10
In vitro and in vivo characterization on amorphous solid dispersion of cyclosporine A for inhalation therapy.用于吸入治疗的环孢素 A 无定形固体分散体的体外和体内表征
J Control Release. 2009 Aug 19;138(1):16-23. doi: 10.1016/j.jconrel.2009.04.014. Epub 2009 Apr 17.